BackRhelion Life Sciences Overview

Rhelion Life Sciences Receivables

Latest receivables for TRUFF: $450K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$454553.00
↓ 6.66% YoYΔ $-32410.00 vs prior year quarter

Peer trimmed avg / median

Loading

Rhelion Life Sciences Receivables History

Loading

Rhelion Life Sciences vs. peers: Receivables Comparison

Loading

Rhelion Life Sciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rhelion Life Sciences (TRUFF) FAQ

The latest receivables for TRUFF is $450K as of June 2026. That compares with $490K in the prior-year period — down 6.7% year over year. Investors often review this figure alongside Rhelion Life Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, TRUFF's receivables moved from $490K to $450K — a 6.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Rhelion Life Sciences's operating scale or balance-sheet position.

A receivables figure of $450K for TRUFF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TRUFF's receivables ($450K), review year-over-year change from $490K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers